查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2088858

腦脊髓液管理市場：依產品類型、適應症和最終用戶分類－2026-2032年全球市場預測

Cerebral Spinal Fluid Management Market by Product Type, Indication, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，腦脊髓液管理市場將成長至 28.5 億美元，複合年成長率為 6.40%。

主要市場統計數據
基準年 2025 18.4億美元
預計年份：2026年 19.5億美元
預測年份 2032 28.5億美元
複合年成長率 (%) 6.40%

腦脊髓液管理市場概覽

腦脊髓液 (CSF) 管理是神經外科和神經重症監護的關鍵領域，其重點在於診斷、監測、分流和恢復腦脊髓液動力學，適用於水腦症、創傷性腦損傷、顱內壓增高、蛛網膜下腔感染疾病、中樞神經系統水腦症等疾病。此領域涵蓋腦室腹腔分流術及腦室心房分流術、腦室外引流術、腰椎引流系統、顱內壓神經科學用內視鏡手術、抗菌導管、閥門、儲液囊及相關手術服務。

腦脊髓液管理領域的變革性變化

腦脊髓液（CSF）管理領域正經歷變革，精準引流、感染控制技術、可程式設計閥門系統以及微創神經外科手術方法正推動著這項變革。可程式設計分流器和可調節閥門在支援水腦症和正常水腦症的個體化治療方面正變得日益重要，因為臨床醫生無需再次手術即可調整壓力設定。隨著醫院將預防醫療相關感染和神經外科器械相關併發症列為優先事項，抗菌導管和含抗生素導管的重要性也日益凸顯。

人工智慧（AI）對腦脊髓液（CSF）管理的累積影響

人工智慧 (AI) 正透過影像分析、工作流程優先排序、預測風險建模和遠端監測等方式，開始影響腦脊髓液 (CSF) 管理。 AI 驅動的放射學工具可以幫助早期發現腦室擴大、中線偏移、出血以及其他與腦脊髓液分流決策相關的觀察。美國食品藥物管理局(FDA) 維護一份公開的、使用 AI 和機器學習技術的醫療設備清單，這表明臨床 AI 領域的監管活動正在加速推進，尤其是在放射學和神經病學等影像密集型專科領域。

全球腦脊髓液管理的關鍵區域性見解

北美憑藉其先進的神經外科基礎設施、先進的影像診斷技術、完善的保險報銷機制以及對可程式設計分流器、抗菌導管、體外腦室引流方案和神經重症監護標準的積極應用，仍然是腦脊髓液管理領域的領先地區。美國透過大規模的醫院網路、大學附屬神經外科中心以及大量的腦水腦症確診患者來滿足區域需求，而加拿大則受益於其協調的公共醫療保健系統和專業的神經外科轉診網路。

策略市場擴張的關鍵群洞察

在東協地區，醫院基礎設施的擴建、神經外科訓練計畫的加強以及新加坡、泰國、馬來西亞、印尼、越南和菲律賓等國CT和MRI設備的普及，都推動了市場需求的成長。該地區的市場機會龐大，而先進腦脊髓液引流系統的應用需要柔軟性的定價策略、強大的經銷商、外科醫生培訓、可靠的庫存和完善的維護支援。

各國腦脊髓液管理的關鍵見解

美國是最具影響力的市場，這得益於其大規模的神經外科醫生群體、高昂的醫療費用支出、健全的醫療設備創新生態系統以及成熟的先進分流和引流技術。在加拿大，省級醫療保健系統和專科轉診中心強調公平的醫療服務取得；而在墨西哥，私立醫院的三級醫療能力和應用正在不斷提升。巴西憑藉其大規模的公立和私人醫療保健網路引領拉丁美洲，其需求主要由神經外科培訓中心、都市區專科醫院以及先進診斷影像技術的普及所驅動。

為行業領導者提供的實用建議

產業領導者應優先考慮經臨床驗證的創新技術，這些技術能夠直接解決腦脊髓液 (CSF) 管理中最棘手的挑戰，例如分流管阻塞、感染疾病、引流過度、引流不足、再次手術和診斷延遲。投資應重點關注可程式設計閥門、抗菌材料、整合感測器的引流管、耐用導管設計以及能夠幫助臨床醫生早期發現併發症的工作流程工具。

調查方法

本執行摘要基於系統的二手資料研究方法，利用公開且檢驗的二手信息，包括政府衛生機構、監管資料庫、同行評審的臨床文獻、醫院實踐標準、國際人口統計資料集和醫療設備研究途徑框架。主要參考類別包括神經系統疾病指南、人口老化數據、感染預防原則、人工智慧醫療設備監管資訊以及當地醫療基礎設施指標。

結論

腦脊髓液管理正朝著更實證、數位化和個人化的方向發展。這一市場的發展動力源自於兒童和成人腦水腦症、創傷性腦水腦症、腦出血、感染疾病、顱內壓增高以及與老齡化相關的神經系統疾病等持續存在的臨床需求。醫院和生產者越來越關注減少併發症、提高診斷準確性以及改善長期治療效果。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 腦脊髓液管理市場：依產品類型分類

  • 大劑量投藥系統
  • 體外引流系統
    • 腦室外引流
    • 腰椎引流系統
  • 鞘內泵
    • 計量泵
    • 可程式設計泵浦
  • 水箱和補充裝

第8章 腦脊髓液管理市場：依適應症分類

  • 水腦症
    • 交通性水腦症
    • 正常水腦症
    • 兒童水腦症
  • 假性腦膜膨出
  • 脊髓液滲漏

第9章 腦脊髓液管理市場：依最終用戶分類

  • 門診手術中心
  • 醫院
    • ICU（加護病房）
    • 神經外科中心
  • 專科診所

第10章：腦脊髓液管理市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第11章 腦脊髓液管理市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第12章 腦脊髓液管理市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第13章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第14章：公司簡介

  • B. Braun SE
  • BeckerSmith Medical, Inc.
  • Delta Surgical
  • DESU MEDIKAL AS
  • G.Surgiwear Ltd.
  • Integra LifeSciences Corporation
  • Johnson & Johnson Services, Inc.
  • Kaneka Medix Corporation
  • Lyfboat Technologies Pvt. Ltd.
  • Medtronic PLC
  • Moller Medical GmbH
  • Natus Medical Incorporated
  • SALVAVIDAS PHARMACEUTICAL PVT. LTD
  • Siemens AG
  • SOPHYSA SA
  • Spiegelberg GmbH & Co. KG
Product Code: MRR-AD36CD898157

The Cerebral Spinal Fluid Management Market is projected to grow by USD 2.85 billion at a CAGR of 6.40% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.84 billion
Estimated Year [2026] USD 1.95 billion
Forecast Year [2032] USD 2.85 billion
CAGR (%) 6.40%

Cerebral Spinal Fluid Management Market Introduction

Cerebral spinal fluid management is a critical neurosurgical and neurocritical care domain focused on diagnosing, monitoring, diverting, and restoring cerebrospinal fluid (CSF) dynamics in conditions such as hydrocephalus, traumatic brain injury, intracranial hypertension, subarachnoid hemorrhage, central nervous system infection, and normal pressure hydrocephalus. The market spans ventriculoperitoneal and ventriculoatrial shunts, external ventricular drains, lumbar drainage systems, intracranial pressure monitoring, neuroendoscopy-enabled procedures, antimicrobial catheters, valves, reservoirs, and related procedural services.

Demand is supported by measurable clinical need. Hydrocephalus is recognized by the National Institute of Neurological Disorders and Stroke as a disorder affecting infants, children, and adults, while the Hydrocephalus Association reports that more than 1 million people in the United States live with hydrocephalus. Global aging is also expanding the population at risk for normal pressure hydrocephalus and complex neurological differential diagnoses, with the United Nations projecting that people aged 65 years and older will more than double globally between 2022 and 2050.

For healthcare systems, the strategic priority is shifting from device placement alone to comprehensive CSF pathway management that reduces shunt malfunction, infection, revision surgery, length of stay, and readmission. For manufacturers and providers, performance depends on evidence-based product innovation, infection prevention, AI-enabled decision support, surgeon training, reimbursement alignment, and regional access expansion.

Transformative Shifts in the CSF Management Landscape

The CSF management landscape is being reshaped by a move toward precision drainage, infection-resistant technologies, programmable valve systems, and minimally invasive neurosurgical approaches. Programmable shunts and adjustable valves are increasingly important because they allow clinicians to modify pressure settings without surgical revision, supporting individualized care in hydrocephalus and normal pressure hydrocephalus. Antimicrobial and antibiotic-impregnated catheters are also gaining relevance as hospitals prioritize prevention of healthcare-associated infections and neurosurgical device-related complications.

Care delivery is moving toward integrated neurocritical care pathways. External ventricular drains are no longer viewed only as drainage devices; they are central to intracranial pressure management, CSF sampling, and acute neurological monitoring. Hospitals are standardizing insertion bundles, sterile handling, line-access discipline, and surveillance protocols based on infection prevention guidance from public health authorities and professional societies.

Another structural shift is the increasing use of neuroimaging, endoscopic third ventriculostomy, and multidisciplinary assessment to determine whether patients require shunting, endoscopic intervention, temporary drainage, or conservative management. This shift is especially important in aging populations, where normal pressure hydrocephalus can overlap clinically with Parkinsonian syndromes, Alzheimer's disease, vascular dementia, and gait disorders.

Cumulative Impact of Artificial Intelligence on CSF Management

Artificial intelligence is beginning to influence CSF management through imaging analysis, workflow prioritization, predictive risk modeling, and remote monitoring. AI-enabled radiology tools can support faster detection of ventricular enlargement, midline shift, hemorrhage, and other findings relevant to CSF diversion decisions. The U.S. Food and Drug Administration maintains a public list of AI and machine learning-enabled medical devices, demonstrating accelerating regulatory activity in clinical AI, particularly in imaging-heavy specialties such as radiology and neurology-adjacent care.

The cumulative impact of AI is expected to be strongest where it augments rather than replaces clinical decision-making. In CSF management, this includes identifying patients who may benefit from normal pressure hydrocephalus workup, flagging changes in ventricular size over time, predicting shunt failure risk, and supporting ICU teams managing intracranial pressure trends. These capabilities can reduce diagnostic delay, improve care coordination, and support earlier escalation when drainage failure, overdrainage, infection, or obstruction is suspected.

However, adoption depends on data quality, explainability, interoperability with electronic health records, cybersecurity, and prospective clinical validation. Industry leaders should prioritize AI tools trained on diverse datasets, validated against clinically meaningful endpoints, and integrated into neurosurgical workflows without adding documentation burden.

Key Regional Insights Across Global CSF Management

North America remains a leading region for cerebral spinal fluid management due to advanced neurosurgical infrastructure, high imaging utilization, established reimbursement pathways, and strong adoption of programmable shunts, antimicrobial catheters, external ventricular drainage protocols, and neurocritical care standards. The United States anchors regional demand through large hospital networks, academic neurosurgery centers, and a substantial diagnosed hydrocephalus population, while Canada benefits from coordinated public healthcare systems and specialized neurosurgical referral networks.

Europe shows steady demand supported by universal healthcare coverage, aging demographics, and strong clinical guideline adoption across major markets. The European Union's medical device regulatory environment, including Medical Device Regulation requirements, is increasing emphasis on clinical evidence, post-market surveillance, product traceability, and risk management, which favors manufacturers with robust quality systems. The United Kingdom, Germany, France, Italy, and Spain are key contributors, while broader European demand is shaped by access to advanced neurosurgery, rehabilitation services, and structured care pathways for normal pressure hydrocephalus and acute neurocritical conditions.

Asia-Pacific is one of the most dynamic opportunity regions as China, India, Japan, South Korea, Australia, and ASEAN countries expand neurosurgical capacity, private hospital networks, imaging access, and medical technology procurement. Latin America, led by Brazil and Mexico, is advancing through tertiary care expansion and public-private investment, although affordability and specialist access remain important constraints. The Middle East, particularly GCC countries, is investing in advanced hospitals, international accreditation, and medical tourism, while Africa faces the largest access gaps, with demand shaped by pediatric hydrocephalus, infection-related neurological complications, limited neurosurgical workforce density, and the need for cost-effective shunt systems.

Key Group Insights for Strategic Market Expansion

Within ASEAN, demand is shaped by expanding hospital infrastructure, rising neurosurgical training capacity, and increasing access to CT and MRI in countries such as Singapore, Thailand, Malaysia, Indonesia, Vietnam, and the Philippines. The region's opportunity is significant, but pricing flexibility, distributor strength, surgeon education, inventory reliability, and maintenance support are essential for adoption of advanced CSF drainage systems.

The GCC is emerging as a high-value group for premium neurosurgical technologies due to sustained investment in tertiary hospitals, specialist recruitment, digital health, and international accreditation. Saudi Arabia, the United Arab Emirates, Qatar, Kuwait, Bahrain, and Oman are prioritizing advanced care pathways that can support adoption of programmable shunts, infection prevention technologies, neurocritical care monitoring, and AI-enabled imaging workflows.

The European Union is defined by evidence-driven procurement, Medical Device Regulation compliance, health technology assessment, and post-market surveillance expectations. BRICS countries represent a scale-driven opportunity, with China, India, and Brazil combining large patient populations with expanding healthcare infrastructure, while Russia and South Africa face more variable access dynamics. G7 countries lead in research intensity, regulatory sophistication, reimbursement maturity, and early adoption of high-value devices. NATO markets overlap substantially with North American and European defense-medical systems, where traumatic brain injury, neurocritical care readiness, emergency preparedness, and hospital resilience support sustained investment in CSF management capabilities.

Key Country Insights in Cerebral Spinal Fluid Management

The United States is the most influential country market because of its large neurosurgical base, high healthcare expenditure, strong device innovation ecosystem, and established use of advanced shunt and drainage technologies. Canada emphasizes equitable access through provincial healthcare systems and specialized referral centers, while Mexico is expanding tertiary care capacity and private hospital adoption. Brazil leads Latin America through large public and private healthcare networks, and its demand is reinforced by neurosurgical training centers, urban specialty hospitals, and growing access to advanced imaging.

In Europe, the United Kingdom, Germany, France, Italy, and Spain are major markets supported by aging populations, public reimbursement, and established neurosurgical expertise. Germany's hospital infrastructure and medical technology ecosystem strengthen adoption, while France and the United Kingdom emphasize evidence-based care pathways and health system evaluation. Italy and Spain maintain demand through regional healthcare systems and specialist neurosurgical centers. Russia has a sizable population base and clinical need, though procurement conditions, regional access, and technology availability may vary.

In Asia-Pacific, China and India represent high-volume growth opportunities due to large populations, expanding hospital capacity, rising access to neurological care, and increasing investment in tertiary services. Japan has advanced neurosurgical capabilities and a rapidly aging population that increases relevance for normal pressure hydrocephalus evaluation. South Korea combines sophisticated hospitals with strong digital health adoption, while Australia benefits from high clinical standards, specialist referral networks, public-private hospital capacity, and established access to advanced medical devices.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize clinically validated innovation that directly addresses the most persistent CSF management challenges: shunt obstruction, infection, overdrainage, underdrainage, revision surgery, and delayed diagnosis. Investment should focus on programmable valves, antimicrobial materials, sensor-enabled drainage, durable catheter design, and workflow tools that help clinicians detect complications earlier.

Manufacturers should build region-specific commercialization strategies. In mature markets, evidence generation, health economics, post-market surveillance, and integration with hospital quality metrics are decisive. In emerging markets, success depends on affordability, surgeon training, distributor reliability, inventory availability, sterile handling education, and service support. Partnerships with academic neurosurgery centers, pediatric hospitals, and neurocritical care units can accelerate adoption and generate real-world evidence.

Providers should standardize infection prevention bundles, drainage protocols, and multidisciplinary normal pressure hydrocephalus pathways. They should also evaluate AI-enabled tools cautiously, requiring transparent validation, cybersecurity safeguards, workflow compatibility, and measurable improvements in time-to-diagnosis, patient selection, complication detection, or resource utilization.

Research Methodology

This executive summary is based on a structured secondary research approach using publicly available, verifiable sources, including government health agencies, regulatory databases, peer-reviewed clinical literature, hospital practice standards, international demographic datasets, and medical device policy frameworks. Key reference categories include neurological disorder guidance, population aging data, infection prevention principles, AI-enabled medical device regulatory information, and regional healthcare infrastructure indicators.

The analysis applies market triangulation by comparing clinical burden, installed neurosurgical capacity, reimbursement maturity, regulatory conditions, hospital procurement behavior, and technology adoption patterns across regions, economic groups, and priority countries. Qualitative insights were synthesized from evidence-based trends in hydrocephalus care, neurocritical care, imaging, device innovation, and hospital quality improvement.

All interpretations are framed to avoid unsupported numerical claims. Where quantitative context is included, it is tied to widely recognized institutional sources such as national health agencies, international organizations, or established disease associations.

Conclusion

Cerebral spinal fluid management is entering a more evidence-driven, digitally enabled, and patient-specific phase. The market is supported by durable clinical need across pediatric hydrocephalus, adult hydrocephalus, traumatic brain injury, hemorrhage, infection, intracranial hypertension, and aging-related neurological disorders. Hospitals and manufacturers are increasingly focused on reducing complications, improving diagnostic precision, and strengthening long-term outcomes.

Future competitive advantage will depend on the ability to combine device performance with clinical evidence, AI-enabled workflow support, infection prevention, and regional access strategies. Organizations that align innovation with measurable patient outcomes, health system priorities, and regulatory expectations will be best positioned to lead the global CSF management market.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Cerebral Spinal Fluid Management Market, by Product Type

  • 7.1. Bolus Delivery Systems
  • 7.2. External Drainage Systems
    • 7.2.1. External Ventricular Drainage
    • 7.2.2. Lumbar Drainage Systems
  • 7.3. Intrathecal Pumps
    • 7.3.1. Fixed-Rate Pumps
    • 7.3.2. Programmable Pumps
  • 7.4. Reservoirs & Refill Kits

8. Cerebral Spinal Fluid Management Market, by Indication

  • 8.1. Hydrocephalus
    • 8.1.1. Communicating Hydrocephalus
    • 8.1.2. Normal Pressure Hydrocephalus
    • 8.1.3. Pediatric Hydrocephalus
  • 8.2. Pseudomeningocele
  • 8.3. Spinal CSF Leak

9. Cerebral Spinal Fluid Management Market, by End User

  • 9.1. Ambulatory Surgical Centers
  • 9.2. Hospitals
    • 9.2.1. ICU Departments
    • 9.2.2. Neurosurgery Centers
  • 9.3. Specialty Clinics

10. Cerebral Spinal Fluid Management Market, by Region

  • 10.1. Asia-Pacific
  • 10.2. North America
  • 10.3. Latin America
  • 10.4. Europe
  • 10.5. Middle East
  • 10.6. Africa

11. Cerebral Spinal Fluid Management Market, by Group

  • 11.1. ASEAN
  • 11.2. GCC
  • 11.3. European Union
  • 11.4. BRICS
  • 11.5. G7
  • 11.6. NATO

12. Cerebral Spinal Fluid Management Market, by Country

  • 12.1. United States
  • 12.2. Canada
  • 12.3. Mexico
  • 12.4. Brazil
  • 12.5. United Kingdom
  • 12.6. Germany
  • 12.7. France
  • 12.8. Russia
  • 12.9. Italy
  • 12.10. Spain
  • 12.11. China
  • 12.12. India
  • 12.13. Japan
  • 12.14. Australia
  • 12.15. South Korea

13. Competitive Landscape

  • 13.1. Market Concentration Analysis, 2025
    • 13.1.1. Concentration Ratio (CR)
    • 13.1.2. Herfindahl Hirschman Index (HHI)
  • 13.2. Recent Developments & Impact Analysis, 2025
  • 13.3. Product Portfolio Analysis, 2025
  • 13.4. Benchmarking Analysis, 2025

14. Company Profiles

  • 14.1. B. Braun SE
  • 14.2. BeckerSmith Medical, Inc.
  • 14.3. Delta Surgical
  • 14.4. DESU MEDIKAL A.S.
  • 14.5. G.Surgiwear Ltd.
  • 14.6. Integra LifeSciences Corporation
  • 14.7. Johnson & Johnson Services, Inc.
  • 14.8. Kaneka Medix Corporation
  • 14.9. Lyfboat Technologies Pvt. Ltd.
  • 14.10. Medtronic PLC
  • 14.11. Moller Medical GmbH
  • 14.12. Natus Medical Incorporated
  • 14.13. SALVAVIDAS PHARMACEUTICAL PVT. LTD
  • 14.14. Siemens AG
  • 14.15. SOPHYSA SA
  • 14.16. Spiegelberg GmbH & Co. KG

LIST OF FIGURES

  • FIGURE 1. GLOBAL CEREBRAL SPINAL FLUID MANAGEMENT MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL CEREBRAL SPINAL FLUID MANAGEMENT MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL CEREBRAL SPINAL FLUID MANAGEMENT MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL CEREBRAL SPINAL FLUID MANAGEMENT MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL CEREBRAL SPINAL FLUID MANAGEMENT MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL CEREBRAL SPINAL FLUID MANAGEMENT MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY INDICATION, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL BOLUS DELIVERY SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL BOLUS DELIVERY SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL BOLUS DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL EXTERNAL DRAINAGE SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL EXTERNAL DRAINAGE SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL EXTERNAL DRAINAGE SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL EXTERNAL VENTRICULAR DRAINAGE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL EXTERNAL VENTRICULAR DRAINAGE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL EXTERNAL VENTRICULAR DRAINAGE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL LUMBAR DRAINAGE SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL LUMBAR DRAINAGE SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL LUMBAR DRAINAGE SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL INTRATHECAL PUMPS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL INTRATHECAL PUMPS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL INTRATHECAL PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL FIXED-RATE PUMPS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL FIXED-RATE PUMPS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL FIXED-RATE PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL PROGRAMMABLE PUMPS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL PROGRAMMABLE PUMPS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL PROGRAMMABLE PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL RESERVOIRS & REFILL KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL RESERVOIRS & REFILL KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL RESERVOIRS & REFILL KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL HYDROCEPHALUS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL HYDROCEPHALUS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL HYDROCEPHALUS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL COMMUNICATING HYDROCEPHALUS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL COMMUNICATING HYDROCEPHALUS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL COMMUNICATING HYDROCEPHALUS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL NORMAL PRESSURE HYDROCEPHALUS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL NORMAL PRESSURE HYDROCEPHALUS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL NORMAL PRESSURE HYDROCEPHALUS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL PEDIATRIC HYDROCEPHALUS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL PEDIATRIC HYDROCEPHALUS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL PEDIATRIC HYDROCEPHALUS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL PSEUDOMENINGOCELE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL PSEUDOMENINGOCELE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL PSEUDOMENINGOCELE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL SPINAL CSF LEAK MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL SPINAL CSF LEAK MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL SPINAL CSF LEAK MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ICU DEPARTMENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ICU DEPARTMENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ICU DEPARTMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL NEUROSURGERY CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL NEUROSURGERY CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL NEUROSURGERY CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY EXTERNAL DRAINAGE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY INTRATHECAL PUMPS, 2018-2032 (USD MILLION)
  • TABLE 67. ASIA-PACIFIC CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 68. ASIA-PACIFIC CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY HYDROCEPHALUS, 2018-2032 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 71. NORTH AMERICA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 72. NORTH AMERICA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 73. NORTH AMERICA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY EXTERNAL DRAINAGE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 74. NORTH AMERICA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY INTRATHECAL PUMPS, 2018-2032 (USD MILLION)
  • TABLE 75. NORTH AMERICA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 76. NORTH AMERICA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY HYDROCEPHALUS, 2018-2032 (USD MILLION)
  • TABLE 77. NORTH AMERICA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 78. NORTH AMERICA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 79. LATIN AMERICA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 80. LATIN AMERICA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 81. LATIN AMERICA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY EXTERNAL DRAINAGE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 82. LATIN AMERICA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY INTRATHECAL PUMPS, 2018-2032 (USD MILLION)
  • TABLE 83. LATIN AMERICA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 84. LATIN AMERICA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY HYDROCEPHALUS, 2018-2032 (USD MILLION)
  • TABLE 85. LATIN AMERICA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 86. LATIN AMERICA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 89. EUROPE CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY EXTERNAL DRAINAGE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY INTRATHECAL PUMPS, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY HYDROCEPHALUS, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 95. MIDDLE EAST CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 96. MIDDLE EAST CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 97. MIDDLE EAST CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY EXTERNAL DRAINAGE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 98. MIDDLE EAST CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY INTRATHECAL PUMPS, 2018-2032 (USD MILLION)
  • TABLE 99. MIDDLE EAST CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 100. MIDDLE EAST CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY HYDROCEPHALUS, 2018-2032 (USD MILLION)
  • TABLE 101. MIDDLE EAST CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 102. MIDDLE EAST CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 103. AFRICA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 104. AFRICA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 105. AFRICA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY EXTERNAL DRAINAGE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 106. AFRICA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY INTRATHECAL PUMPS, 2018-2032 (USD MILLION)
  • TABLE 107. AFRICA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 108. AFRICA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY HYDROCEPHALUS, 2018-2032 (USD MILLION)
  • TABLE 109. AFRICA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 110. AFRICA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 112. ASEAN CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 113. ASEAN CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 114. ASEAN CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY EXTERNAL DRAINAGE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 115. ASEAN CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY INTRATHECAL PUMPS, 2018-2032 (USD MILLION)
  • TABLE 116. ASEAN CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 117. ASEAN CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY HYDROCEPHALUS, 2018-2032 (USD MILLION)
  • TABLE 118. ASEAN CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 119. ASEAN CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 120. GCC CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 121. GCC CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. GCC CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY EXTERNAL DRAINAGE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 123. GCC CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY INTRATHECAL PUMPS, 2018-2032 (USD MILLION)
  • TABLE 124. GCC CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 125. GCC CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY HYDROCEPHALUS, 2018-2032 (USD MILLION)
  • TABLE 126. GCC CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 127. GCC CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPEAN UNION CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPEAN UNION CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPEAN UNION CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY EXTERNAL DRAINAGE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPEAN UNION CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY INTRATHECAL PUMPS, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPEAN UNION CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPEAN UNION CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY HYDROCEPHALUS, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPEAN UNION CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPEAN UNION CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 136. BRICS CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 137. BRICS CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 138. BRICS CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY EXTERNAL DRAINAGE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 139. BRICS CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY INTRATHECAL PUMPS, 2018-2032 (USD MILLION)
  • TABLE 140. BRICS CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 141. BRICS CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY HYDROCEPHALUS, 2018-2032 (USD MILLION)
  • TABLE 142. BRICS CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 143. BRICS CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 144. G7 CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 145. G7 CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 146. G7 CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY EXTERNAL DRAINAGE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 147. G7 CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY INTRATHECAL PUMPS, 2018-2032 (USD MILLION)
  • TABLE 148. G7 CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 149. G7 CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY HYDROCEPHALUS, 2018-2032 (USD MILLION)
  • TABLE 150. G7 CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 151. G7 CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 152. NATO CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 153. NATO CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. NATO CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY EXTERNAL DRAINAGE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 155. NATO CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY INTRATHECAL PUMPS, 2018-2032 (USD MILLION)
  • TABLE 156. NATO CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 157. NATO CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY HYDROCEPHALUS, 2018-2032 (USD MILLION)
  • TABLE 158. NATO CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 159. NATO CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 160. GLOBAL CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 161. UNITED STATES CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 162. UNITED STATES CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. UNITED STATES CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY EXTERNAL DRAINAGE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 164. UNITED STATES CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY INTRATHECAL PUMPS, 2018-2032 (USD MILLION)
  • TABLE 165. UNITED STATES CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 166. UNITED STATES CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY HYDROCEPHALUS, 2018-2032 (USD MILLION)
  • TABLE 167. UNITED STATES CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 168. UNITED STATES CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 169. CANADA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 170. CANADA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 171. CANADA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY EXTERNAL DRAINAGE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 172. CANADA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY INTRATHECAL PUMPS, 2018-2032 (USD MILLION)
  • TABLE 173. CANADA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 174. CANADA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY HYDROCEPHALUS, 2018-2032 (USD MILLION)
  • TABLE 175. CANADA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 176. CANADA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 177. MEXICO CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 178. MEXICO CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 179. MEXICO CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY EXTERNAL DRAINAGE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 180. MEXICO CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY INTRATHECAL PUMPS, 2018-2032 (USD MILLION)
  • TABLE 181. MEXICO CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 182. MEXICO CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY HYDROCEPHALUS, 2018-2032 (USD MILLION)
  • TABLE 183. MEXICO CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 184. MEXICO CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 185. BRAZIL CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 186. BRAZIL CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 187. BRAZIL CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY EXTERNAL DRAINAGE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 188. BRAZIL CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY INTRATHECAL PUMPS, 2018-2032 (USD MILLION)
  • TABLE 189. BRAZIL CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 190. BRAZIL CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY HYDROCEPHALUS, 2018-2032 (USD MILLION)
  • TABLE 191. BRAZIL CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 192. BRAZIL CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 193. UNITED KINGDOM CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 194. UNITED KINGDOM CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 195. UNITED KINGDOM CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY EXTERNAL DRAINAGE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 196. UNITED KINGDOM CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY INTRATHECAL PUMPS, 2018-2032 (USD MILLION)
  • TABLE 197. UNITED KINGDOM CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 198. UNITED KINGDOM CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY HYDROCEPHALUS, 2018-2032 (USD MILLION)
  • TABLE 199. UNITED KINGDOM CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 200. UNITED KINGDOM CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 201. GERMANY CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 202. GERMANY CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. GERMANY CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY EXTERNAL DRAINAGE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 204. GERMANY CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY INTRATHECAL PUMPS, 2018-2032 (USD MILLION)
  • TABLE 205. GERMANY CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 206. GERMANY CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY HYDROCEPHALUS, 2018-2032 (USD MILLION)
  • TABLE 207. GERMANY CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 208. GERMANY CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 209. FRANCE CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 210. FRANCE CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 211. FRANCE CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY EXTERNAL DRAINAGE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 212. FRANCE CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY INTRATHECAL PUMPS, 2018-2032 (USD MILLION)
  • TABLE 213. FRANCE CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 214. FRANCE CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY HYDROCEPHALUS, 2018-2032 (USD MILLION)
  • TABLE 215. FRANCE CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 216. FRANCE CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 217. RUSSIA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 218. RUSSIA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 219. RUSSIA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY EXTERNAL DRAINAGE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 220. RUSSIA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY INTRATHECAL PUMPS, 2018-2032 (USD MILLION)
  • TABLE 221. RUSSIA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 222. RUSSIA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY HYDROCEPHALUS, 2018-2032 (USD MILLION)
  • TABLE 223. RUSSIA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 224. RUSSIA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 225. ITALY CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 226. ITALY CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 227. ITALY CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY EXTERNAL DRAINAGE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 228. ITALY CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY INTRATHECAL PUMPS, 2018-2032 (USD MILLION)
  • TABLE 229. ITALY CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 230. ITALY CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY HYDROCEPHALUS, 2018-2032 (USD MILLION)
  • TABLE 231. ITALY CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 232. ITALY CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 233. SPAIN CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 234. SPAIN CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 235. SPAIN CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY EXTERNAL DRAINAGE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 236. SPAIN CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY INTRATHECAL PUMPS, 2018-2032 (USD MILLION)
  • TABLE 237. SPAIN CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 238. SPAIN CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY HYDROCEPHALUS, 2018-2032 (USD MILLION)
  • TABLE 239. SPAIN CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 240. SPAIN CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 241. CHINA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 242. CHINA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 243. CHINA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY EXTERNAL DRAINAGE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 244. CHINA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY INTRATHECAL PUMPS, 2018-2032 (USD MILLION)
  • TABLE 245. CHINA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 246. CHINA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY HYDROCEPHALUS, 2018-2032 (USD MILLION)
  • TABLE 247. CHINA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 248. CHINA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 249. INDIA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 250. INDIA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 251. INDIA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY EXTERNAL DRAINAGE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 252. INDIA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY INTRATHECAL PUMPS, 2018-2032 (USD MILLION)
  • TABLE 253. INDIA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 254. INDIA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY HYDROCEPHALUS, 2018-2032 (USD MILLION)
  • TABLE 255. INDIA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 256. INDIA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 257. JAPAN CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 258. JAPAN CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 259. JAPAN CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY EXTERNAL DRAINAGE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 260. JAPAN CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY INTRATHECAL PUMPS, 2018-2032 (USD MILLION)
  • TABLE 261. JAPAN CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 262. JAPAN CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY HYDROCEPHALUS, 2018-2032 (USD MILLION)
  • TABLE 263. JAPAN CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 264. JAPAN CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 265. AUSTRALIA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 266. AUSTRALIA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 267. AUSTRALIA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY EXTERNAL DRAINAGE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 268. AUSTRALIA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY INTRATHECAL PUMPS, 2018-2032 (USD MILLION)
  • TABLE 269. AUSTRALIA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 270. AUSTRALIA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY HYDROCEPHALUS, 2018-2032 (USD MILLION)
  • TABLE 271. AUSTRALIA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 272. AUSTRALIA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 273. SOUTH KOREA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 274. SOUTH KOREA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 275. SOUTH KOREA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY EXTERNAL DRAINAGE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 276. SOUTH KOREA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY INTRATHECAL PUMPS, 2018-2032 (USD MILLION)
  • TABLE 277. SOUTH KOREA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 278. SOUTH KOREA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY HYDROCEPHALUS, 2018-2032 (USD MILLION)
  • TABLE 279. SOUTH KOREA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 280. SOUTH KOREA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)